INFLUENCE OF ACUTE CORONARY SYNDROME ON INTRAOPERATIVE DYNAMICS OF IL-6 DURING CORONARY REVASCULARIZATION

Keywords: coronary artery stenting, interlekin-6, acute coronary syndrome

Abstract

Percutaneous x-ray endovascular angioplasty is one of the most modern methods of treatment of severe forms of cardiovascular diseases. In the pathogenesis of acute coronary syndrome, a special place is occupied by the proinflammatory reaction of the body. The main “secondary” marker is interlekin-6. The peak of its production occurs on the first day of damage and correlates with its size.

The aim of the study. To investigate the dynamics of interleukin-6 level in the perioperative period of coronary revascularization, depending on the presence of acute coronary syndrome.

Materials and methods. This study included 68 patients with coronary artery disease. The patients were divided into three study groups. Group 1 and 2 patients were diagnosed with ACS, and they underwent emergency stenting of coronary vessels in order to recanalize occlusion of the coronary arteries. 3rd group patients did not have ACS and they were recanalized as planned.

Results. Analyzing the results of the study, we found that the highest obtained values of IL-6 were in group 1 in comparison with the group of patients who were surgically treated as planned and after stent placement, the interleukin values were 24.8 % higher in group 1 than in group 2 and almost 4 times higher in group 3 (p<0.001). When comparing groups with acute coronary syndrome, interleukin-6 indices were significantly higher by 47.4 % before surgery in group 3 and by 24.9 % after stent placement, which once again confirms the severity of patients with acute myocardial infarction.

Conclusions. Intraoperatively proinflammatory interlekin-6 after coronary artery stenting tends to increase in groups with acute coronary syndrome, while in the group with stable angina, these indicators are significantly higher by 22.8 % (p <0.001). The dynamics of Il-6 levels clearly correlates with the severity of the patient's condition and increases in the presence of acute coronary syndrome, especially in the presence of acute myocardial infarction.

Downloads

Download data is not yet available.

Author Biographies

Dmytro Dziuba, Shupyk National Medical Academy of Postgraduate Education

Department of anesthesiology and intensive care

 
Serhii Veremchuk, Shupyk National Medical Academy of Postgraduate Education; Feofaniya Clinical Hospital of State Management of Affairs of Ukraine

Department of anesthesiology and intensive care

 
Oleh Loskutov, Shupyk National Medical Academy of Postgraduate Education; State Institution "Heart Institute of the Ministry of health of Ukraine"

Department of anesthesiology and intensive care

 

References

Movsisyan, N. K., Vinciguerra, M., Medina-Inojosa, J. R., Lopez-Jimenez, F. (2020). Cardiovascular Diseases in Central and Eastern Europe: A Call for More Surveillance and Evidence-Based Health Promotion. Annals of Global Health, 86 (1). doi: http://doi.org/10.5334/aogh.2713

Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S. et. al. (2018). Heart Disease and Stroke Statistics–2018 Update: A Report From the American Heart Association. Circulation, 137 (12), 67–492. doi: http://doi.org/10.1161/cir.0000000000000573

Mehta, N. K., Abrams, L. R., Myrskylä, M. (2020). US life expectancy stalls due to cardiovascular disease, not drug deaths. Proceedings of the National Academy of Sciences, 117 (13), 6998–7000. doi: http://doi.org/10.1073/pnas.1920391117

Bhupathi, V., Mazariegos, M., Cruz Rodriguez, J. B., Deoker, A. (2020). Dairy Intake and Risk of Cardiovascular Disease. Current Cardiology Reports, 22 (3). doi: http://doi.org/10.1007/s11886-020-1263-0

Jones, J., Furze, G., Buckley, J. (2020). Cardiovascular Disease Prevention and Rehabilitation. Cardiovascular Prevention and Rehabilitation in Practice, 1–19. doi: http://doi.org/10.1002/9781119071006.ch1

Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P. et. al. (2020). Heart disease and stroke statistics – 2020 update: a report from the American Heart Association. Circulation, E139–E596.

Gaziano, T. A., Pandya, A., Sy, S., Jardim, T. V., Ogden, J. M., Rodgers, A., Weinstein, M. C. (2019). Modeling the cost effectiveness and budgetary impact of Polypills for secondary prevention of cardiovascular disease in the United States. American Heart Journal, 214, 77–87. doi: http://doi.org/10.1016/j.ahj.2019.04.020

Santos, J. V., Vandenberghe, D., Lobo, M., Freitas, A. (2020). Cost of cardiovascular disease prevention: towards economic evaluations in prevention programs. Annals of Translational Medicine, 8 (7), 512. doi: http://doi.org/10.21037/atm.2020.01.20

Kovalenko, V. M., Kornatskiy, V. M. (Eds.) (2018). Actual health problems and their minimization in the context of armed conflict in Ukraine. Kyiv: SPD FO «Kolomitsyn VYu», 214.

Prabhu, S. D., Frangogiannis, N. G. (2016). The Biological Basis for Cardiac Repair After Myocardial Infarction. Circulation Research, 119 (1), 91–112. doi: http://doi.org/10.1161/circresaha.116.303577

Seropian, I. M., Sonnino, C., Van Tassell, B. W., Biasucci, L. M., Abbate, A. (2015). Inflammatory markers in ST-elevation acute myocardial infarction. European Heart Journal: Acute Cardiovascular Care, 5 (4), 382–395. doi: http://doi.org/10.1177/2048872615568965

Mourouzis, K., Oikonomou, E., Siasos, G., Tsalamadris, S., Vogiatzi, G., Antonopoulos, A. et. al. (2020). Proinflammatory Cytokines in Acute Coronary Syndromes. Current Pharmaceutical Design, 26. doi: http://doi.org/10.2174/1381612826666200413082353

Zeng, C., Wang, R., Tan, H. (2019). Role of Pyroptosis in Cardiovascular Diseases and its Therapeutic Implications. International Journal of Biological Sciences, 15 (7), 1345–1357. doi: http://doi.org/10.7150/ijbs.33568

Jou, C., Shah, R., Figueroa, A., Patel, J. K. (2018). The Role of Inflammatory Cytokines in Cardiac Arrest. Journal of Intensive Care Medicine, 35 (3), 219–224. doi: http://doi.org/10.1177/0885066618817518

Francis Stuart, S. D., De Jesus, N. M., Lindsey, M. L., Ripplinger, C. M. (2016). The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction. Journal of Molecular and Cellular Cardiology, 91, 114–122. doi: http://doi.org/10.1016/j.yjmcc.2015.12.024

Walter, J., Tanglay, Y., du Fay de Lavallaz, J., Strebel, I., Boeddinghaus, J., Twerenbold, R. et. al. (2019). Clinical utility of circulating interleukin-6 concentrations in the detection of functionally relevant coronary artery disease. International Journal of Cardiology, 275, 20–25. doi: http://doi.org/10.1016/j.ijcard.2018.10.029

Ashiq, S. et. al. (2020). Prevalence and role of different risk factors with emphasis on genetics in development of pathophysiology of coronary artery disease (cad). Pakistan Heart Journal, 52 (4).

Moore, K. J. (2018). Targeting inflammation in CVD: advances and challenges. Nature Reviews Cardiology, 16 (2), 74–75. doi: http://doi.org/10.1038/s41569-018-0144-3

Vaidya, K., Martínez, G., Patel, S. (2019). The Role of Colchicine in Acute Coronary Syndromes. Clinical Therapeutics, 41 (1), 11–20. doi: http://doi.org/10.1016/j.clinthera.2018.07.023

González-Castro, T. B., Hernández-Díaz, Y., Pérez-Hernández, N., Tovilla-Zárate, C. A., Juárez-Rojop, I. E., López-Narvaez, M. L. et. al. (2019). Interleukin 6 (rs1800795) gene polymorphism is associated with cardiovascular diseases: a meta-analysis of 74 studies with 86,229 subjects. EXCLI journal, 18, 331–355. doi: http://doi.org/10.17179/excli2019-1248

Hansen, P. R., Nelveg-Kristensen, K. E., Rasmussen, H. B., Torp-Pedersen, C., Køber, L., Nielsen, C. H., Enevold, C. (2019). Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure. The Pharmacogenomics Journal, 19 (5), 428–437. doi: http://doi.org/10.1038/s41397-019-0068-2


👁 249
⬇ 122
Published
2020-09-29
How to Cite
Dziuba, D., Veremchuk, S., & Loskutov, O. (2020). INFLUENCE OF ACUTE CORONARY SYNDROME ON INTRAOPERATIVE DYNAMICS OF IL-6 DURING CORONARY REVASCULARIZATION. EUREKA: Health Sciences, (5), 16-21. https://doi.org/10.21303/2504-5679.2020.001413
Section
Medicine and Dentistry